ATE270332T1 - Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen - Google Patents
Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungenInfo
- Publication number
- ATE270332T1 ATE270332T1 AT99946160T AT99946160T ATE270332T1 AT E270332 T1 ATE270332 T1 AT E270332T1 AT 99946160 T AT99946160 T AT 99946160T AT 99946160 T AT99946160 T AT 99946160T AT E270332 T1 ATE270332 T1 AT E270332T1
- Authority
- AT
- Austria
- Prior art keywords
- basb033
- polynucleotide
- polypeptide
- neisseria meningitidis
- polypeptides
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000040430 polynucleotide Human genes 0.000 title abstract 2
- 108091033319 polynucleotide Proteins 0.000 title abstract 2
- 239000002157 polynucleotide Substances 0.000 title abstract 2
- 241000588650 Neisseria meningitidis Species 0.000 title 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9820003.3A GB9820003D0 (en) | 1998-09-14 | 1998-09-14 | Novel compounds |
| PCT/EP1999/006718 WO2000015801A1 (en) | 1998-09-14 | 1999-09-09 | Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE270332T1 true ATE270332T1 (de) | 2004-07-15 |
Family
ID=10838842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99946160T ATE270332T1 (de) | 1998-09-14 | 1999-09-09 | Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US6627204B1 (de) |
| EP (1) | EP1112366B1 (de) |
| JP (1) | JP2002528057A (de) |
| CN (1) | CN1245419C (de) |
| AT (1) | ATE270332T1 (de) |
| AU (1) | AU5862299A (de) |
| CA (1) | CA2343314A1 (de) |
| DE (1) | DE69918446T2 (de) |
| DK (1) | DK1112366T3 (de) |
| ES (1) | ES2226438T3 (de) |
| GB (1) | GB9820003D0 (de) |
| HK (1) | HK1038041A1 (de) |
| PT (1) | PT1112366E (de) |
| WO (1) | WO2000015801A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2371994C (en) * | 1999-02-26 | 2010-09-28 | Guido Grandi | Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs |
| NO20002828D0 (no) * | 2000-06-02 | 2000-06-02 | Statens Inst For Folkehelse | Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav |
| GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| GB0103424D0 (en) * | 2001-02-12 | 2001-03-28 | Chiron Spa | Gonococcus proteins |
| JP2006506467A (ja) | 2002-08-02 | 2006-02-23 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン組成物 |
| GB2414667A (en) * | 2004-06-03 | 2005-12-07 | Isis Innovation | Vaccine compositions of N. meningitidis PorA and FetA antigens |
| WO2010027499A2 (en) * | 2008-09-05 | 2010-03-11 | University Of Massachusetts Medical School | Methods, compositions and vaccines relating to neisseria meningitidis antibodies |
| JP2013521770A (ja) | 2010-03-10 | 2013-06-13 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン組成物 |
| ES2654613T3 (es) | 2012-02-02 | 2018-02-14 | Glaxosmithkline Biologicals Sa | Promotores para una expresión aumentada de proteínas en meningococos |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2751000B1 (fr) * | 1996-07-12 | 1998-10-30 | Inst Nat Sante Rech Med | Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques |
-
1998
- 1998-09-14 GB GBGB9820003.3A patent/GB9820003D0/en not_active Ceased
-
1999
- 1999-09-09 DE DE69918446T patent/DE69918446T2/de not_active Expired - Lifetime
- 1999-09-09 AU AU58622/99A patent/AU5862299A/en not_active Abandoned
- 1999-09-09 CN CNB99813242XA patent/CN1245419C/zh not_active Expired - Fee Related
- 1999-09-09 JP JP2000570328A patent/JP2002528057A/ja not_active Withdrawn
- 1999-09-09 PT PT99946160T patent/PT1112366E/pt unknown
- 1999-09-09 EP EP99946160A patent/EP1112366B1/de not_active Expired - Lifetime
- 1999-09-09 WO PCT/EP1999/006718 patent/WO2000015801A1/en active IP Right Grant
- 1999-09-09 AT AT99946160T patent/ATE270332T1/de active
- 1999-09-09 CA CA002343314A patent/CA2343314A1/en not_active Abandoned
- 1999-09-09 US US09/787,084 patent/US6627204B1/en not_active Expired - Fee Related
- 1999-09-09 ES ES99946160T patent/ES2226438T3/es not_active Expired - Lifetime
- 1999-09-09 DK DK99946160T patent/DK1112366T3/da active
-
2001
- 2001-12-20 HK HK01108956A patent/HK1038041A1/xx not_active IP Right Cessation
-
2003
- 2003-04-17 US US10/417,885 patent/US7071321B2/en not_active Expired - Fee Related
-
2005
- 2005-08-03 US US11/196,976 patent/US20050272091A1/en not_active Abandoned
-
2006
- 2006-09-29 US US11/541,501 patent/US20080219986A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2343314A1 (en) | 2000-03-23 |
| EP1112366B1 (de) | 2004-06-30 |
| DE69918446D1 (de) | 2004-08-05 |
| CN1245419C (zh) | 2006-03-15 |
| US20030224012A1 (en) | 2003-12-04 |
| ES2226438T3 (es) | 2005-03-16 |
| AU5862299A (en) | 2000-04-03 |
| JP2002528057A (ja) | 2002-09-03 |
| US6627204B1 (en) | 2003-09-30 |
| DK1112366T3 (da) | 2004-11-01 |
| US20050272091A1 (en) | 2005-12-08 |
| WO2000015801A1 (en) | 2000-03-23 |
| GB9820003D0 (en) | 1998-11-04 |
| PT1112366E (pt) | 2004-11-30 |
| HK1038041A1 (en) | 2002-03-01 |
| US20080219986A1 (en) | 2008-09-11 |
| CN1326508A (zh) | 2001-12-12 |
| EP1112366A1 (de) | 2001-07-04 |
| US7071321B2 (en) | 2006-07-04 |
| DE69918446T2 (de) | 2005-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69928658T2 (de) | Basb029 polynucleotide und polypeptide aus neisseria meningitis | |
| WO1999055873A3 (en) | Basb006 polynucleotide(s) and polypeptides from neisseria meningitis | |
| ATE270332T1 (de) | Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen | |
| PL345793A1 (en) | Neisseria meningitidis | |
| DE60134253D1 (de) | Basb205 polypeptide und dafür kodierende polynukleotide | |
| WO2000043519A3 (en) | Neisseria meningitidis polypeptides | |
| DE60140006D1 (de) | Polypeptide aus haemophilus influenza | |
| ATE527360T1 (de) | Neue verbindungen abgeleitet von neisseria meningitidis | |
| DE60043658D1 (de) | Basb118 polypeptid und polynukleotid aus moraxella catarrhalis | |
| ATE360073T1 (de) | Basb119 polypeptid und polynukleotid aus moraxella catarrhalis | |
| ATE311458T1 (de) | Basb111 polypeptid und polynukleotid aus moraxella catharralis | |
| ATE399205T1 (de) | Immunogene polypeptide aus moraxella catarrhalis und deren verwendungen | |
| ATE515511T1 (de) | Nicht-typisierbare haemophilus influenzae basb201 polypeptide und polynukleotide und deren verwendungen | |
| ATE274582T1 (de) | Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis | |
| ATE293693T1 (de) | Moraxella catarrhalis antigen basb117 | |
| DE60035788D1 (de) | Polypeptide aus moraxella (branhamella) catarrhalis | |
| ATE293692T1 (de) | Moraxella catarrhalis antigen basb120 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1112366 Country of ref document: EP |